Company Overview:
Gene Bridges, a self-financed biotech company, pioneers recombineering, the fast and precise method of engineering gene sequences. Founded in 2000 as am EMBL spin-off, it commercialises its patented Red/ET Recombination technology through services, commercial licenses and kits and is represented by distributors world-wide.
Brand Names:
Red/ET Recombination
This Exhibitor offers products & services in the following categories:
• Biotechnology and Related Specialties
» Genomics
» Molecular Biology
• Scientific, Research and Contract Services
» Contract Manufacturing
» Contract Research
• Technology and Software
» Enabling and Platform Technologies